[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-hiway":3,"related-news-Hiway--":109},{"data":4},{"_id":5,"slug":6,"availabilityStates":7,"content":8,"createdAt":9,"description":10,"locationCount":11,"logo":12,"name":13,"productCount":14,"rank":11,"registryData":15,"sourceIds":16,"sourceUpdatedAt":18,"updatedAt":19,"uuids":20,"catalogEntityType":22,"catalogSources":23,"countryCodes":26,"marketSlugs":29,"marketRegions":32,"officialCatalog":15,"sourceAttributions":34,"marketProductCounts":38,"products":41,"categories":106,"licensedAvailabilityStates":108},"6a8f3c5aa59e70fa6d87934f","hiway",[],null,"2026-08-26T18:40:15.609Z","Hiway products are listed from official regulated catalogs in CA. VeedAtlas tracks the markets and source records attached to this catalog.",0,"","Hiway",4,true,[17],"28625","2026-08-27T15:06:46.000Z","2026-08-27T15:06:55.493Z",[21],"e5d0e54c-65d9-4b9e-977d-2ad7ed36a97b","consumer_brand",[24,25],"jane","ocs",[27,28],"US","CA",[30,31],"united-states","canada",[33],"Ontario",[35],{"sourceKey":25,"sourceName":36,"sourceUrl":37,"marketSlug":31,"countryCode":28,"region":33},"Ontario Cannabis Store","https:\u002F\u002Focs.ca\u002F",{"united-states":39,"canada":40},1,3,[42,61,78,91],{"_id":43,"slug":44,"name":45,"brand":13,"brandSlug":6,"category":46,"type":47,"thc":11,"cbd":11,"image":48,"imageLarge":49,"rating":11,"reviews":11,"marketSlugs":50,"countryCodes":51,"marketRegions":52,"officialCatalog":53,"hasAvailability":53,"storeCount":11,"seo":54},"6a8f3c2ea59e70fa6d8656dd","hiway-aaa-hybrid","AAA Hybrid","flower","hybrid","https:\u002F\u002Fproduct-assets.iheartjane.com\u002Fcdn-cgi\u002Fimage\u002Fwidth=327,fit=scale-down,format=auto,metadata=none\u002Fphotos\u002F58\u002Fa6\u002F58a6ce07-a340-4541-9435-8a51d5f72d9f.jpeg","https:\u002F\u002Fproduct-assets.iheartjane.com\u002Fcdn-cgi\u002Fimage\u002Fwidth=1000,fit=scale-down,format=auto,metadata=none\u002Fphotos\u002F58\u002Fa6\u002F58a6ce07-a340-4541-9435-8a51d5f72d9f.jpeg",[30],[27],[],false,{"indexable":53,"score":55,"reasons":56,"descriptionFingerprint":58,"descriptionDuplicateCount":39,"eligibleMarkets":59,"evaluatedAt":60},70,[57],"insufficient_source_evidence","9eb22774e19a5f7a176e14fc1e7214da8c38cbb53b6585f1b731355d57b0c1b3",[],"2026-08-27T18:01:04.515Z",{"_id":62,"slug":63,"name":64,"brand":13,"brandSlug":6,"category":65,"type":65,"thc":66,"cbd":39,"image":67,"imageLarge":67,"rating":11,"reviews":11,"marketSlugs":68,"countryCodes":69,"marketRegions":70,"officialCatalog":15,"price":71,"priceCurrency":72,"hasAvailability":53,"storeCount":11,"seo":73},"6a90528ba59e70fa6d87d301","hiway-indica-pre-roll","Indica Pre-Roll","Flower",26,"https:\u002F\u002Fcdn.shopify.com\u002Fs\u002Ffiles\u002F1\u002F2636\u002F1928\u002Ffiles\u002F00688083014437_a1c1_compress_104185_c39a6564-47e8-4216-8ae8-151dfa556c78.jpg?v=1778375980",[31],[28],[33],10.95,"CAD",{"indexable":15,"score":74,"reasons":75,"descriptionFingerprint":76,"descriptionDuplicateCount":39,"eligibleMarkets":77,"evaluatedAt":60},100,[],"3736b033cfa04155f1b7bac506b2ea5841afbc4c8af02d79f96310bd9f018ba9",[31],{"_id":79,"slug":80,"name":81,"brand":13,"brandSlug":6,"category":65,"type":65,"thc":82,"cbd":39,"image":83,"imageLarge":83,"rating":11,"reviews":11,"marketSlugs":84,"countryCodes":85,"marketRegions":86,"officialCatalog":15,"price":71,"priceCurrency":72,"hasAvailability":53,"storeCount":11,"seo":87},"6a90528ba59e70fa6d87d302","hiway-sativa-pre-roll","Sativa Pre-Roll",25,"https:\u002F\u002Fcdn.shopify.com\u002Fs\u002Ffiles\u002F1\u002F2636\u002F1928\u002Ffiles\u002F00688083014420_a1c1_compress_104184_5a37ae2d-739c-40c7-b246-f68ba86c94de.jpg?v=1778375979",[31],[28],[33],{"indexable":15,"score":74,"reasons":88,"descriptionFingerprint":89,"descriptionDuplicateCount":39,"eligibleMarkets":90,"evaluatedAt":60},[],"76d3be619e1fbffc973623773142834091add380d295a6abc8660d820ae84a8d",[31],{"_id":92,"slug":93,"name":94,"brand":13,"brandSlug":6,"category":65,"type":65,"thc":95,"cbd":96,"image":97,"imageLarge":97,"rating":11,"reviews":11,"marketSlugs":98,"countryCodes":99,"marketRegions":100,"officialCatalog":15,"price":101,"priceCurrency":72,"hasAvailability":53,"storeCount":11,"seo":102},"6a90528ba59e70fa6d87d2b4","hiway-slow-lane-indica","Slow Lane Indica",28,0.1,"https:\u002F\u002Fcdn.shopify.com\u002Fs\u002Ffiles\u002F1\u002F2636\u002F1928\u002Ffiles\u002F00688083014710_a1cc_compressed_110158_63cef61a-8cbd-4907-acf1-4a84b2e35d1a.jpg?v=1784877591",[31],[28],[33],18.75,{"indexable":15,"score":74,"reasons":103,"descriptionFingerprint":104,"descriptionDuplicateCount":39,"eligibleMarkets":105,"evaluatedAt":60},[],"90c6281acf70a7c571328214863226f8cd641edf1dcb031184288f9a935d47e0",[31],[107],{"name":46,"count":14},[],{"data":110,"pagination":183},[111],{"_id":112,"slug":113,"articleType":114,"body":115,"createdAt":124,"dek":125,"entities":126,"headline":149,"imageAlt":150,"imageUrl":12,"keyFacts":151,"language":171,"publishedAt":172,"seo":173,"sources":176,"summary":181,"updatedAt":182},"6a909aefaeddfad21a39f9ed","canopy-growth-shifts-focus-to-fundamentals-plans-brand-cull-and-european-expansion-1ae3fa1c","finance",[116,117,118,119,120,121,122,123],"Canopy Growth is set to streamline its brand portfolio as it builds a multi-market, seed-to-patient model, distancing itself from a legacy of 'false starts', according to CEO Luc Mongeau. Speaking as he approaches his second anniversary as chief, Mongeau emphasized a focus on delivery and transforming Canopy from a financial instrument into a real cannabis company.","First quarter fiscal 2027 results, for the period ending June, showed overall revenues increased 13%, gross margin rose by 6% to 31%, and adjusted EBITDA loss narrowed by 59% to C$3.2 million. With the stock hovering near $1, Canopy has established a platform for a potential reverse share split to protect its NASDAQ listing, which Mongeau described as a purely defensive play if the stock underperforms.","Mongeau highlighted cost-cutting efforts, stating the company has cut and is in the process of cutting upwards of C$40 million of unnecessary costs. The balance-sheet debt is now in the C$230 to C$280 million range, with maturities largely extended to 2031, dramatically lower than peak debt levels from the high-valuation era.","The CEO explained that the board and management were previously preoccupied with financing and financial markets rather than fundamentals like yield, THC, terpenes, and market penetration. He noted that Canopy, as a pioneer, chased many opportunities and invested heavily in the US market, leading to a lack of focus on fundamentals.","To execute 'mission two', Canopy acquired Canadian cannabis producer MTL Cannabis for C$125 million earlier this year, including Apollo Cannabis and Canada House Clinics for patient consultations, and Abba Medix, a patient pharmacy. These complement Spectrum Therapeutics, Canopy's medical arm, creating a domestic seed-to-patient model that Mongeau aims to replicate globally.","In Europe, Canopy has a presence in the German and Polish medical markets and is delivering its first medical products to the UK. Total European revenues are C$40 million, with ambitions to quadruple this over the next few years. The company recently secured EU-GMP certification for its 300,000 sq ft Kincardine, Ontario facility to support this goal.","On the recreational side, Canopy's premium brand is Tweed, with partnerships for Claybourne and Jetty brands and ownership of Storz & Bickel. Of its 13 brands, including HiWay and R'belle, Mongeau said the company is sorting through them and will have a very focused portfolio by the end of the fiscal year.","Mongeau summarized his tenure as moving from a company focused on possibilities and seen as a financial instrument to a real operating company in a concrete market, building momentum.","2026-08-27T20:15:43.285Z","CEO Luc Mongeau outlines a seed-to-patient strategy, cost cuts, and a potential reverse share split to protect its NASDAQ listing.",{"brands":127,"products":134,"markets":135,"organizations":141},[128,129,130,131,132,133],"Tweed","Claybourne","Jetty","Storz & Bickel","HiWay","R'belle",[],[136,137,138,139,140,27],"Canada","Germany","Poland","UK","Europe",[142,143,144,145,146,147,148],"Canopy Growth","MTL Cannabis","Apollo Cannabis","Canada House Clinics","Abba Medix","Spectrum Therapeutics","NASDAQ","Canopy Growth Shifts Focus to Fundamentals, Plans Brand Cull and European Expansion","Canopy Growth CEO Luc Mongeau discussing the company's strategic shift to fundamentals and seed-to-patient model.",[152,156,159,162,165,168],{"claim":153,"sourceUrl":154,"_id":155},"Canopy Growth's Q1 fiscal 2027 revenues increased 13%, gross margin rose to 31%, and adjusted EBITDA loss narrowed by 59% to C$3.2 million.","https:\u002F\u002Fbusinessofcannabis.com\u002Fcanopy-growths-seed-to-patient-model-set-to-debut-in-europe\u002F","6a909aefe81f0249cd72dca8",{"claim":157,"sourceUrl":154,"_id":158},"Canopy Growth is considering a reverse share split to protect its NASDAQ listing if the stock underperforms.","6a909aefe81f0249cd72dca9",{"claim":160,"sourceUrl":154,"_id":161},"Canopy Growth has cut or is cutting over C$40 million in unnecessary costs and reduced balance-sheet debt to C$230-280 million with maturities extended to 2031.","6a909aefe81f0249cd72dcaa",{"claim":163,"sourceUrl":154,"_id":164},"Canopy Growth acquired MTL Cannabis for C$125 million, including Apollo Cannabis, Canada House Clinics, and Abba Medix, to build a seed-to-patient model.","6a909aefe81f0249cd72dcab",{"claim":166,"sourceUrl":154,"_id":167},"Canopy Growth's European revenues are C$40 million, with plans to quadruple them, and it recently secured EU-GMP certification for its Kincardine facility.","6a909aefe81f0249cd72dcac",{"claim":169,"sourceUrl":154,"_id":170},"Canopy Growth will have a focused brand portfolio by the end of the fiscal year, reviewing its 13 brands including Tweed, Claybourne, Jetty, Storz & Bickel, HiWay, and R'belle.","6a909aefe81f0249cd72dcad","en","2026-08-28T05:26:14.544Z",{"title":174,"description":175},"Canopy Growth Focuses on Fundamentals, Plans Brand Cull","Canopy Growth CEO Luc Mongeau outlines seed-to-patient strategy, cost cuts, and European expansion after Q1 revenue rise.",[177],{"name":178,"url":154,"trustTier":179,"_id":180},"Business of Cannabis","trade","6a909aefe81f0249cd72dca7","Canopy Growth is pivoting from a 'financial instrument' to a real cannabis company, with CEO Luc Mongeau announcing a brand portfolio review, a seed-to-patient model expansion in Europe, and improved Q1 fiscal 2027 results including a 13% revenue increase and narrowed adjusted EBITDA loss.","2026-08-28T05:26:14.748Z",{"page":39,"limit":40,"total":39,"pages":39}]